An app-based, one-to-one peer support program from Shift.ms that connects people newly diagnosed with multiple sclerosis (MS) with someone more experienced may help them feel more confident in managing their condition, with self-reported psychological benefits for both people in the pairing. That’s according to five-year…

Abnormal fat buildup inside the brain’s immune cells may help to drive neurological damage and disability progression in people with progressive forms of multiple sclerosis (MS), a study found. The findings also point to a possible therapeutic target. Researchers showed that blocking an enzyme called…

MSAA features the work of many talented artists affected by multiple sclerosis as part of our annual MSAA Art Showcase. Each month we share these artists’ inspiring stories and beautiful artwork with you as our Artist of the Month. This month, we celebrate Chris Pero as June’s … Continue reading → Source:…

Three years of treatment with Sanofi’s investigational antibody therapy frexalimab was associated with persistently low disease activity and no new safety concerns in people with relapsing forms of multiple sclerosis (MS). That’s according to new data from an ongoing open-label extension phase of a global…

Tweet This is a question I have posed and answered. Are they the same? You know that you can have them as an infusion or at home and they inhibit relapses and new lesion formation and this class of drug has become one of the…

I had a terrible and embarrassing experience within the last week. I can’t even believe I’m gonna write about it it’s embarrassing but that’s what this site is for. This experience definitely falls under the dark category in the travails of Bethy Bright and Dark.…